Skip to main content
. 2019 Dec 10;2019(4):hoz030. doi: 10.1093/hropen/hoz030

Table II.

Outcome of the FAS population at the 2-year follow-up.

Weight reduction and IVF group IVF only group p-value odds ratio (95%CI)
Cumulative live birth rate * 87/152 (57.2) 82/153 (53.6) 0.56 1.16 (0.74 to 1.52)
No. of participants in the follow-up 137 139
No. of additional live births after index cycle 42 40
Additional live birth rate 42/137 (30.7) 40/139 (28.8)
Way of conception
 IVF/ICSI 20/42 (47.6) 20/40 (50)
 FET 11/42 (26.2) 9/40 (22.5)
 Spontaneous pregnancies 9/42 (21.4) 9/40 (22.5)
 Oocyte donation/ 1/42 (2.4) 0 (0.0)
 Gonadotrophin stimulation 1/42 (2.4) 0 (0.0)
 Unknown 0 (0.0) 2/40 (5.0)
Ongoing pregnancies 19 16
 ‐ Expecting first child in the study 10/137 (7.3) 7/139 (5.0)
 ‐ Expecting second child in the study 9/137 (6.6) 9/139 (6.5)
Way of conception
 IVF/ICSI 6/19 (31.6) 4/16 (25.0)
 FET 4/19 (21.1) 1/16 (6.3)
 Spontaneous pregnancy 9/19 (47.4) 9/16 (56.3)
 Oocyte donation/ 0 (0.0) 1/16 (6.3)
 Unknown 0 (0.0) 1/16 (6.3)
Cumulative live birth rate/ongoing pregnancy rate 97/152 (63.8) 89/153 (58.2) 0.34 1.28 (0.8 to 2.01)
Total no. of started IVF/ICSI cycles ** 214 244
Total no. of FET ** 70 74

FAS: full analysis set, FET: frozen embryo transfer.

For categorical variables, n (%) is presented.

For comparison between groups, Fisher’s Exact test (lowest 1-sided p-value multiplied by 2) was used for dichotomous variables.

*Cumulative live birth defined as at least one child born alive. Calculated on all FAS patients 152/153.

**Missing data from one Danish clinic concerning any follow-up treatments performed by the nine patients in the weight reduction and IVF group and the seven patients from the IVF-only group.